Original article
Parental Attitudes and Beliefs Regarding the Nine-Valent Human Papillomavirus Vaccine

https://doi.org/10.1016/j.jadohealth.2015.09.003Get rights and content

Abstract

Purpose

The purpose of the study was to explore parents' attitudes and beliefs about the nine-valent human papillomavirus vaccine (HPV9).

Methods

Online focus groups were conducted in January, 2015. The U.S. national sample of parents was recruited to four groups: (1) two groups of parents of HPV unvaccinated daughters aged 9–12 years and (2) two groups of parents of vaccinated daughters aged 11–17 years.

Results

Participants were 43 parents of vaccinated daughters and 38 parents of unvaccinated daughters. Results indicated low and variable levels of knowledge about HPV, related cancers, and vaccination (e.g., parents unaware vaccine is recommended for boys). Parents were encouraged that HPV9 covered more types, and many said they want the “better” vaccine. Parents of unvaccinated girls wondered whether they should delay vaccination until HPV9 was available, whereas parents of vaccinated girls wondered whether their daughters could be revaccinated with HPV9. Concerns were related to adverse reactions and side effects, whether another new vaccine will be released after HPV9, HPV mutation (i.e., will HPV types change over time—thereby necessitating multiple vaccines?), and cost. Physician recommendation was identified as the most important facilitator of vaccination, with participants wanting providers to exhibit high levels of confidence in and knowledge about HPV vaccines. Last, parents also viewed the prospective idea of a 2-dose HPV9 vaccine as positive.

Conclusions

HPV9 recently became available in the United States and has the potential to offer greater cancer prevention if widespread acceptance and uptake occur. Understanding parental perceptions and questions about HPV9 will be important for clinical messaging about this vaccine.

Section snippets

Methods

Online focus groups were conducted in January, 2015, with a U.S. national convenience sample of parents. A total of four focus groups were convened: two groups of parents of HPV unvaccinated daughters aged 9–12 years and two groups of parents of fully vaccinated daughters aged 11–17 years. This study focused on female vaccination as parental beliefs on vaccination may differ based on a child's sex; subsequent work should include parents of males. In addition, HPV9 has greater potential benefit

Demographic characteristics

The final sample consisted of 81 parents of 97 daughters. Forty-three were parents of fully vaccinated (three-dose completion) daughters; 38 were parents of unvaccinated daughters. The parents were diverse, representing 31 states and all nine U.S. Census regions [11]. The majorities of parents were female, had completed some college or obtained a college degree, were employed full time, and were married. See Table 2 for sociodemographic information on parents and daughters.

Qualitative analysis

Four main categories

Discussion

Consistent with other research on HPV vaccination, we found that most parents see HCP recommendation as among the most important factors in deciding about vaccination [12], [13], [14]. Parents clearly valued HCP expertise and expected their daughters' providers to be well informed about HPV9 and to be able to answer any questions that arise. It was notable, however, that there remained substantial gaps in knowledge and misunderstanding about the reasons for the recommendation to vaccinate all

Funding Sources

Support for this study was provided by Indiana University-Purdue University Center for HPV Research, which is funded by the Indiana University-Purdue University Signature Centers Initiative and the support of the IU School of Medicine, Department of Pediatrics and the IU Simon Cancer Center, and Boston College Internal Start-up Funds awarded to Dr. Fontenot.

References (19)

There are more references available in the full text version of this article.

Cited by (22)

  • Cancer Prevention Education for Providers, Staff, Parents, and Teens Improves Adolescent Human Papillomavirus Immunization Rates

    2019, Journal of Pediatrics
    Citation Excerpt :

    Such effects might impact vaccination rates among small groups of friends, but it is also feasible that larger scale influences could develop across those attending a particular school or to a larger number of teens living in the same community. A strong vaccine recommendation from a provider who is confident and knowledgeable about the HPV vaccine in addition to messages regarding HPV vaccine as cancer prevention motivates HPV vaccinations.38-40 Our multicomponent intervention was associated with small to moderate increases in HPV vaccination rates among the recruited practices.

  • Understanding the Two-Dose HPV Vaccine Schedule

    2018, Nursing for Women's Health
    Citation Excerpt :

    In addition, research should explore the impact of the two-dose schedule on U.S. vaccination rates. Authors of previous research highlighted the fact that parents believed that a 9vHPV two-dose schedule would be easier, more convenient, and less expensive and would facilitate vaccine dosing completion (Fontenot, Domush, & Zimet, 2015). However, despite these benefits, it is possible that nurses and other health care providers may experience difficulties transitioning from the three-dose to the two-dose schedule.

  • Parental acceptance of human papillomavirus vaccinations and community pharmacies as vaccination settings: A qualitative study in Alabama

    2017, Papillomavirus Research
    Citation Excerpt :

    Disparities in knowledge also exist; parents of adolescents in rural areas are less aware of the HPV vaccine because they are less likely to be presented with the information [5,6]. Recommendations from healthcare professionals are key to HPV vaccine acceptability [7–10]. Interestingly, physicians do not rank the HPV vaccine as important when compared to other vaccines (Tdap and meningococcal vaccines) and often discuss the HPV vaccine last during patient visits [11].

  • Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine

    2016, European Journal of Cancer
    Citation Excerpt :

    The nonavalent vaccine may be seen by parents as going ‘back to square one’ in terms of the evidence of long-term efficacy, as it is newly developed. One online focus group study of parents of vaccinated and unvaccinated girls, conducted in the USA, identified concern about side-effects of the nonavalent vaccine [18]. Worry about possible long-term side-effects of first generation HPV vaccines is a well-established barrier to vaccine acceptance, and centres on the lack of long-term surveillance data due to the vaccine's novelty [14,15].

  • A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine

    2016, Vaccine
    Citation Excerpt :

    Most HCPs did not anticipate that parents or patients would have questions about 9vHPV. This finding is particularly interesting in light of a recent study by Fontenot et al. which found that parents had many questions about 9vHPV, including concerns about safety and whether yet another HPV vaccine might be developed in the near future [17]. However, the differences between what the providers in this study anticipated and what Fontenot et al. found could be due to different patient populations.

View all citing articles on Scopus
View full text